PARP1 and neoplasm: Further investigation of tumor infiltration of immune cells and cGAS/STING knockout studies identified CD8+ T‐cell recruitment via STING pathway activation as a critical determinant of the anti‐tumor immunity efficacy of PARP inhibition and CDC7i in OV (Figure7).